Anisodowleh Nankali1, Nader Salari2, Mohsen Kazeminia3, Masoud Mohammadi4, Samira Rasoulinya1, Melika Hosseinian-Far5. 1. Department of Obstetrics and Gynecology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. 2. Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran. n_s_514@yahoo.com. 3. Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran. 4. Department of Nursing, School of Nursing and Midwifery, Kermanshah University of Medical Sciences, Kermanshah, Iran. Masoud.mohammadi1989@yahoo.com. 5. Department of Food Science & Technology, Faculty of Agriculture, Ferdowsi University of Mashhad (FUM), Mashhad, Iran.
Abstract
BACKGROUND: Placenta previa describes a placenta that extends partially or completely over the internal cervical oss. Placenta previa is one of the leading causes of widespread postpartum hemorrhage and maternal mortality worldwide. Another cause of bleeding in pregnant women is Placenta accreta spectrum. Therefore, the aim of the present systematic review and meta-analysis is to determine the effect of prophylactic balloon occlusion of the internal iliac arteries in patients with placenta previa or placental accreta spectrum (PAS). METHODS: In this systematic review and meta-analysis, to identify and select relevant studies, the SID, MagIran, ScienceDirect, Embase, Scopus, PubMed, Web of Science, and Google Scholar databases were searched, using the keywords of internal iliac artery balloon, placenta, previa, balloon, accreta, increta and percreta, without a lower time limit and until 2020. The heterogeneity of the studies was examined using the I2 index, and subsequently a random effects model was applied. Data analysis was performed within the Comprehensive Meta-Analysis software (version 2). RESULTS: In the review of 29 articles with a total sample size of 1140 in the control group, and 1225 in the balloon occlusion group, the mean difference between the two groups was calculated in terms of Intraoperative blood loss index (mL) and it was derived as 3.21 ± 0.38; moreover, in 15 studies with a sample size of 887 in the control group, and 760 in the balloon occlusion group, the mean difference between the two groups in terms of gestation index (weeks) was found as 2.84 ± 0.49; and also with regards to hysterectomy balloon occlusion after prophylactic closure of the iliac artery, hysterectomy (%) balloon occlusion was calculated as 8.9 %, and this, in the hysterectomy control group (%) was obtained as 31.2 %; these differences were statistically significant and showed a positive effect of the intervention (P < 0.05). CONCLUSION: The results of this study show that the use of prophylactic internal iliac artery balloon occlusion in patients with placenta previa or Placenta accreta spectrum has benefits such as reduced intraoperative blood loss, reduced hysterectomy and increased gestation (weeks), which can be considered by midwives and obstetricians.
BACKGROUND: Placenta previa describes a placenta that extends partially or completely over the internal cervical oss. Placenta previa is one of the leading causes of widespread postpartum hemorrhage and maternal mortality worldwide. Another cause of bleeding in pregnant women is Placenta accreta spectrum. Therefore, the aim of the present systematic review and meta-analysis is to determine the effect of prophylactic balloon occlusion of the internal iliac arteries in patients with placenta previa or placental accreta spectrum (PAS). METHODS: In this systematic review and meta-analysis, to identify and select relevant studies, the SID, MagIran, ScienceDirect, Embase, Scopus, PubMed, Web of Science, and Google Scholar databases were searched, using the keywords of internal iliac artery balloon, placenta, previa, balloon, accreta, increta and percreta, without a lower time limit and until 2020. The heterogeneity of the studies was examined using the I2 index, and subsequently a random effects model was applied. Data analysis was performed within the Comprehensive Meta-Analysis software (version 2). RESULTS: In the review of 29 articles with a total sample size of 1140 in the control group, and 1225 in the balloon occlusion group, the mean difference between the two groups was calculated in terms of Intraoperative blood loss index (mL) and it was derived as 3.21 ± 0.38; moreover, in 15 studies with a sample size of 887 in the control group, and 760 in the balloon occlusion group, the mean difference between the two groups in terms of gestation index (weeks) was found as 2.84 ± 0.49; and also with regards to hysterectomy balloon occlusion after prophylactic closure of the iliac artery, hysterectomy (%) balloon occlusion was calculated as 8.9 %, and this, in the hysterectomy control group (%) was obtained as 31.2 %; these differences were statistically significant and showed a positive effect of the intervention (P < 0.05). CONCLUSION: The results of this study show that the use of prophylactic internal iliac artery balloon occlusion in patients with placenta previa or Placenta accreta spectrum has benefits such as reduced intraoperative blood loss, reduced hysterectomy and increased gestation (weeks), which can be considered by midwives and obstetricians.
Authors: Maya Frank Wolf; Jonathan Singer-Jordan; Oleg Shnaider; Ala Aiob; Inshirah Sgayer; Jacob Bornstein Journal: Aust N Z J Obstet Gynaecol Date: 2018-11-08 Impact factor: 2.100
Authors: Leonard J Bodner; John L Nosher; Christopher Gribbin; Randall L Siegel; Stephanie Beale; William Scorza Journal: Cardiovasc Intervent Radiol Date: 2006 May-Jun Impact factor: 2.740
Authors: Alison G Cahill; Richard Beigi; R Phillips Heine; Robert M Silver; Joseph R Wax Journal: Am J Obstet Gynecol Date: 2018-12 Impact factor: 8.661
Authors: Giuseppe Cali; Francesco Forlani; Laura Giambanco; Maria Luisa Amico; Mario Vallone; Giuseppe Puccio; Luigi Alio Journal: Eur J Obstet Gynecol Reprod Biol Date: 2014-05-21 Impact factor: 2.435
Authors: Daniela A Carusi; Karin A Fox; Deirdre J Lyell; Nicola C Perlman; Soroush Aalipour; Brett D Einerson; Michael A Belfort; Robert M Silver; Alireza A Shamshirsaz Journal: Obstet Gynecol Date: 2020-09 Impact factor: 7.661